Oppenheimer downgrades Auxilium Pharmaceuticals (Nasdaq: AUXL) from Outperform to Perform. PT $36.

To see all ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE